Literature DB >> 30657376

Visualization of Cancer and Cardiovascular Disease Co-Occurrence With Network Methods.

Christine W Duarte1, Volkhard Lindner1, Sanjeev A Francis1, Dounya Schoormans1.   

Abstract

PURPOSE: Cancer and cardiovascular disease (CVD) are common causes of morbidity and mortality, and measurement and interpretation of their co-occurrence rate have important implications for public health and patient care. Here, we present the raw and adjusted co-occurrence rates of cancer and CVD in the overall population by using a visually intuitive network approach.
METHODS: By using baseline survey and linked health outcome data from 490,842 individuals age 40 to 69 years from the UK Biobank, we recorded diagnoses between 1997 and 2014 of specific cancers and specific CVDs ascertained through hospital claims. We measured raw and adjusted rates of CVD for the following groups: individuals with Hodgkin or non-Hodgkin lymphoma, lung and trachea cancer, uterus cancer, colorectal cancer, prostate cancer, breast cancer, or no recorded diagnosed cancer during this time period. Analysis accounted for age, sex, and behavioral risk factors, without regard to the order of occurrence of cancer and CVD.
RESULTS: A significantly increased rate of CVD was found in patients with multiple types of cancers, including Hodgkin and non-Hodgkin lymphoma and lung and trachea, uterus, colorectal, and breast cancer, compared with patients without cancer by using age and sex-adjusted models. Increased co-occurrence for many CVD categories remained after correction for behavioral risk factors. Construction of co-occurrence networks highlighted heart failure as a shared CVD diagnosis across multiple cancer types, including breast cancer, lung cancer, non-Hodgkin lymphoma, and colorectal cancer. Smoking, physical activity, and other lifestyle factors accounted for some but not all of the increased co-occurrence for many of the CVD diagnoses.
CONCLUSION: Increased co-occurrence of several common CVD conditions is seen widely across multiple malignancies, and shared diagnoses, such as heart failure, were highlighted by using network methods.

Entities:  

Mesh:

Year:  2017        PMID: 30657376     DOI: 10.1200/CCI.16.00071

Source DB:  PubMed          Journal:  JCO Clin Cancer Inform        ISSN: 2473-4276


  11 in total

Review 1.  A Cardio-Oncology Data Commons: Lessons from Pediatric Oncology.

Authors:  Anant Mandawat; Logan Eberly; William Border
Journal:  Curr Cardiol Rep       Date:  2019-09-13       Impact factor: 2.931

2.  Atrial Cardiomyopathy Predicts Worse Outcome in Patients With Lung Cancer.

Authors:  Mengdi Ren; Yuyan Ma; Meng Wei; Yuye Ning; Hui Liu; Xue Shi; Yu Yao; Fengwei Guo
Journal:  Front Cardiovasc Med       Date:  2022-07-01

3.  The effect of disease co-occurrence measurement on multimorbidity networks: a population-based study.

Authors:  Barret A Monchka; Carson K Leung; Nathan C Nickel; Lisa M Lix
Journal:  BMC Med Res Methodol       Date:  2022-06-08       Impact factor: 4.612

4.  Driver Genes Associated With the Incidence of Venous Thromboembolism in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Authors:  Xiaohan Qian; Mengjiao Fu; Jing Zheng; Jianya Zhou; Jianying Zhou
Journal:  Front Oncol       Date:  2021-04-29       Impact factor: 6.244

5.  Omentin protects H9c2 cells against docetaxel cardiotoxicity.

Authors:  Ricardo Lage; María Cebro-Márquez; Moisés Rodríguez-Mañero; José Ramón González-Juanatey; Isabel Moscoso
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

Review 6.  Cardiac Safety of Osimertinib: A Review of Data.

Authors:  Michael S Ewer; Sri Harsha Tekumalla; Andrew Walding; Kwame N Atuah
Journal:  J Clin Oncol       Date:  2020-12-23       Impact factor: 44.544

7.  Cardiovascular Risk Factors are Associated with Future Cancer.

Authors:  Emily S Lau; Samantha M Paniagua; Elizabeth Liu; Manol Jovani; Shawn X Li; Katherine Takvorian; Navin Suthahar; Susan Cheng; Greta L Splansky; James L Januzzi; Thomas J Wang; Ramachandran S Vasan; Bernard Kreger; Martin G Larson; Daniel Levy; Rudolf A de Boer; Jennifer E Ho
Journal:  JACC CardioOncol       Date:  2021-03-16

8.  Characterizing chronological accumulation of comorbidities in healthy veterans: a computational approach.

Authors:  Julian C Hong; Elizabeth R Hauser; Thomas S Redding; Kellie J Sims; Ziad F Gellad; Meghan C O'Leary; Terry Hyslop; Ashton N Madison; Xuejun Qin; David Weiss; A Jasmine Bullard; Christina D Williams; Brian A Sullivan; David Lieberman; Dawn Provenzale
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.996

9.  Association of colorectal cancer with genetic and epigenetic variation in PEAR1-A population-based cohort study.

Authors:  Wen-Yi Yang; Benedetta Izzi; Adam P Bress; Lutgarde Thijs; Lorena Citterio; Fang-Fei Wei; Erika Salvi; Simona Delli Carpini; Paolo Manunta; Daniele Cusi; Marc F Hoylaerts; Aernout Luttun; Peter Verhamme; Sheetal Hardikar; Tim S Nawrot; Jan A Staessen; Zhen-Yu Zhang
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

10.  New Male Users of Lipid-Lowering Drugs for Primary Prevention of Cardiovascular Disease: The Impact of Treatment Persistence on Morbimortality. A Longitudinal Study.

Authors:  Isabel Aguilar-Palacio; María José Rabanaque; Lina Maldonado; Armando Chaure; José María Abad-Díez; Montse León-Latre; José Antonio Casasnovas; Sara Malo
Journal:  Int J Environ Res Public Health       Date:  2020-10-20       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.